N
Noconda Pharmaceutical
Development of formula foods for special medical purposes
About Noconda Pharmaceutical
Founded in July 2013, Beijing Noconda Pharmaceutical Technology Co., Ltd. operates from the Beijing Economic-Technological Development Area, positioning itself as a comprehensive service provider for the pharmaceutical sector. The firm's business model integrates Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO), and Marketing Authorization Holder (MAH) services. Noconda supplies end-to-end research and development solutions to pharmaceutical enterprises and biomedical parks, assisting them from initial product conception to market launch and beyond.
The company's operational framework is built upon two core pillars: progressive innovation in formulation technology and the application of AI-driven big data models. This dual approach enables Noconda to support its clients in product planning and design, digital R&D management, and the development of product portfolios fortified by patent protection. The service offering is extensive, covering pharmaceutical studies, clinical and non-clinical research, pilot-scale amplification, manufacturing, regulatory affairs services, and analytical testing. Revenue is generated by providing these integrated services to its partners in the pharmaceutical industry.
Noconda has developed a series of specialized technology platforms to address diverse therapeutic areas and drug delivery challenges. These include platforms for AI-driven discovery of biological intelligent polymer materials (MedPolymer AI), ophthalmic and intraocular implants, complex injectable formulations, topical preparations, polypeptide drugs, and oral controlled-release systems, among others. The company's capabilities have enabled its partners to secure 278 regulatory approvals. Through its various subsidiaries, Noconda extends its reach into specialized areas such as the development and import of traditional Chinese medicines, international technology transfer and FDA declaration services, and the R&D of special medical purpose foods.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- China
- Open positions
- 3
- Dealroom signal
- 21.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Nov 2023 | $25M | $99M | Keyuan Pharmaceutical | ↗ |
| GROWTH EQUITY VCEquity / VC | Jan 2019 | $0 | — | Yun Hao Capital | ↗ |
Growth signals
Latest recorded traffic for Noconda Pharmaceutical is 800 monthly website visits, up 1042.9% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Noconda Pharmaceutical in its local ecosystem
The Noconda Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- YCYun Hao Capital
- KPKeyuan Pharmaceutical
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Noconda Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Noconda Pharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









